Redwood Pharma to present at BIO-Europe Spring
Redwood Pharma will present on March 24 in Paris, France, at BIO-Europe Spring, one of Europe's largest life science partnership conferences, where it will give an update on the business and discuss potential and business partnerships for RP101, the company's leading product under development.Redwood Pharma is currently conducting a Phase II clinical trial of RP101 in Europe and has previously announced an intention to publish topline results by the end of March. The presentation will be made by CEO Martin Vidaeus and Professor Gerhard Garhöfer of the Medical University of Vienna.